Abstract submission and pre-registration are now open for the symposium ‘MODELS, CHALLENGES AND PROMISES OF ADVANCED THERAPIES FOR CANCER: NK CELLS IN THE CLINIC AND INDUSTRY’, another IMMUNO-model event!
The event will be held at the Spanish National Centre for Biotechnology (CNB-CSIC) in Madrid, March 5-6, 2026 and will bring together researchers, clinicians and industry experts, offering a unique platform to share recent efforts in innovation on advanced therapies.
The scientific sessions will include keynote talks by international scientists and clinicians, experts in the transfer of new therapies to the clinic and industry. As a novelty, we will have several roundtables in which invited specialists will discuss other crucial aspects to consider when planning translational research such as regulatory issues, how to work in a clean room and business aspects. Talks and roundtables will include these topics:
Talks by experts: Tumour recognition by NK cells, NK cell enhancer biomolecules, Successful NK cell-based therapies in the clinics
Roundtable 1: Regulatory aspects: how to understand guidelines for experimental design, how to reach regulatory agencies
Roundtable 2: The clean room and therapeutics production
Roundtable 3: Advanced therapies from the lab to industry. Science, investment and business aspects
Participants will also have the opportunity to present their ongoing research projects in the field of cancer immunotherapy, aligned with the mission of the IMMUNO-model COST Action: in addition to our invited talks, 8-10 abstracts will be selected for oral presentation and we will also host a poster session.
For this Meeting, IMMUNO-Model COST Action will financially support some attendants with oral presentations. Selected presenters will be eligible to receive reimbursement for travel and accommodation costs, in line with COST Travel Reimbursement Rules, and subject t funds availability. All information can be found here: https://www.cost.eu/uploads/2025/11/COST-094-21-Annotated-Rules-for-COST-Actions-Level-C-V3.0-25-IX-2025.pdf
Pre-registration for abstract submission is open until Jan 9th, 2026.
Please fill Abstract submission and pre-registration form to submit your work.
More information for attendees (venue, etc) and a preliminary program can be found in these links:
Other Important dates
- 09/Jan/2026: deadline for submission of abstracts
- 21/Jan/2026: Communication to successful applicants as oral or poster presentation. Full registration for all attendees opens